Actionable news
0
All posts from Actionable news
Actionable news in BABA: ALIBABA GROUP HOLDING LIMITED,

Ira Sohn Conference 2016: The Live Blog

Invest with Confidence. Are you a financial professional? Stay on top of your portfolio with Benzinga Pro's real-time newsfeed and alerts and never miss a headline again.
Don't miss the chance to try it FREE today.

Amazon.com, Inc. NASDAQ:AMZN, ANTM - Ira Sohn Conference 2016: The Live Blog

Ira Sohn 2016 is minutes away from kicking off; the event is scheduled to begin at noon EDT.

To see a full schedule, click here.

Tune in here to find updates as Benzinga reporters receive them live at the event. Or visit

on Twitter to get the unfiltered feed from everyone on Twitter.

Times below are in Eastern.

2:33pm VR Capital done presenting. Stan Druckenmiller is next.

2:20pm VR Capital likes Greek bank stocks.

2:17pm Smith says Westrock worth $71/share by end of next year, concludes presentation.

2:11pm Smith says Westrock WRK 1.63% is a defensive company and is undervalued; adds dividend has room to increase.

2:08pm Smith says Depomed is substantially undervalued.

2:07pm Smith says Depomed did not engage with Horizon Pharma HZNP 2.95%, took highly aggressive 10% poison pill.

2:05pm Smith says Depomed management wants more M&A, has attractive assets, adds Depomed is attractive to strategic acquirers.

1:59pm Starboard's Jeff Smith talking Depomed DEPO 2.86% on stage, says company has lack of experience in Phase 3 trials.

1:18pm Sohn on a break.

1:14pm Palihapitiya says Amazon turned $18B cost into $200B value.

1:11pm He adds Amazon will be $1.5 trillion business by 2025.

1:09pm Social Capital's Chamath Palihapitiya says Bezos continues to disrupt market.

1:03pm Social Capital's Chamath Palihapitiya talking Amazon.com, Inc. AMZN 0.35%, says he's extremely confident in Prime. Says Facebook and Twitter can't build same infrastructure.

1:00pm Social Capital's Chamath Palihapitiya presenting now.

12:56pm Khourney says Hyatt worth $79, adds drivers of growth are adding hotels to system.

12:55pm Long Pond's Khoury highlighting comments from Warren Buffett that an ideal business is one that takes no capital but grows, hinting Hyatt does this.

12:54pm Chanos says SolarCity gets into financial trouble by 2018. Says he made a mistake covering Sunedison Inc NYSESUNE.

12:53pm Chanos on Tesla: "I think they will definitely need to raise capital."

12:46pm Long Pond Capital's John Khoury at Ira Sohn Discussing Hyatt Hotels Corporation H 0.93%, sees 65% upside.

12:42pm Long Pond's John Khoury next up to present.

12:40pm Waters sees bank taking losses on unfinished projects.

12:39pm Block says Bank of the Ozarks will take losses via large bets, doesn't require personal guarantee from developers.

12:37pm Chanos says investors are valuing Cheniere on a "hoped for" income stream.

12:34pm Block calls Bank of the Ozarks business model "ass backwards."

12:29pm Block talking Bank Of The Ozarks Inc OZRK 4.06%. Stock down 10 percent. Block says bank has $6.3 billion unfunded off balance sheet, adds it can come under severe pressure.

12:27pm Carson Block takes stage.

12:24pm Larry Robbins discussing Anthem/CIGNA deal, said merger likely to go through. "Even if the deal doesn't close the stock still goes higher.

12:23pm Glenview's Robbins says even if Anthem ANTM 1.9% deal doesn't close, stock will go up; believes market pricing in 1/3 chance merger closes.

12:21pm Valeant shares fall as Kynikos' Chanos says he's still short Valeant Pharmaceuticals Intl Inc VRX 2.04%.

12:15pm Larry Robbins discussed Thermo Fisher Scientific, said he's been in the name for 13 years. Called the stock volatile but with "boring and stable" fundamentals.

12:09pm Behind the scenes at Ira Sohn, Kynikos' Jim Chanos tells CNBC's Scott Wapner he is still short Alibaba BABA 0.59% shares.

12:08pm: Robbins says he won't have anything action to discuss in his presentation, instead will focus on "The Benefits of Hanging On."

12:05pm: Glenview's Larry Robbins taking the stage as first presenter at Ira Sohn.

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.